openPR Logo
Press release

Testosterone Replacement Therapy Market to reach $2.9 billion by 2032, growing at a CAGR of 4.2%

04-16-2024 01:53 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Testosterone Replacement Therapy Market to reach $2.9 billion

Testosterone Replacement Therapy Market Overview:

The global testosterone replacement therapy market was valued at $1.9 billion in 2022 and is projected to reach $2.9 billion by 2032, with a CAGR of 4.2% from 2023 to 2032.

Growth Drivers:

Increased prevalence of hypogonadism

Growing awareness of men's health

Surge in the geriatric population

Request Sample of the Report on Testosterone Replacement Therapy Market Forecast - https://www.alliedmarketresearch.com/request-sample/A08394

Key Factors:

Drivers:

Rising prevalence of hypogonadism
Growing geriatric population
Insurance coverage for testosterone replacement therapy

Opportunities:

Technological advancements in therapy methods
Restraints:

Side effects associated with therapy

Impact of 2023 Recession:

The 2023 recession moderately affected the market due to decreased disposable income, impacting therapy adoption. However, recovery is anticipated due to the increasing geriatric population and prevalence of hypogonadism.

Market Segmentation:

By Product Type:

Injectables dominated in 2022, accounting for 75% of revenue. The segment's growth is attributed to cost-effectiveness and efficiency.

Other segments, particularly prolonged release implants, are expected to grow rapidly.

By Active Ingredient:

Testosterone cypionate led in 2022, contributing over a third of revenue.

Testosterone undecanoate is expected to have the highest CAGR due to its availability in various formulations.

By End User:

Clinics were the largest end user in 2022, catering to a significant male patient base with hypogonadism.

Regional Analysis:

North America held the largest market share in 2022 due to its established healthcare infrastructure and growing geriatric population.

Asia-Pacific is projected to have the highest CAGR, driven by increased hypogonadism incidence and obesity prevalence.
Key Players.

Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/A08394

Leading companies in the testosterone replacement therapy market include:

AbbVie Inc.
Besins Healthcare SA
Acerus Pharmaceuticals Corporation
Amneal Pharmaceuticals Inc.
Acrux Ltd.
Endo International Plc
Biote Medical, LLC
Pfizer Inc.
Insud Pharma S.L
Marius Pharmaceuticals

These companies are adopting strategies like acquisitions to expand their market presence.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/A08394

Conclusion:

The report offers a comprehensive analysis of the testosterone replacement therapy market, highlighting growth drivers, challenges, and opportunities. It provides insights into key market players, their strategies, and the competitive landscape.

Contact:

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Testosterone Replacement Therapy Market to reach $2.9 billion by 2032, growing at a CAGR of 4.2% here

News-ID: 3465819 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Testosterone

Rising Testosterone Deficiency Fuels Testosterone Replacement Therapy Market Gro …
"Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Testosterone Replacement Therapy Market Through 2025? The testosterone replacement therapy market size has grown steadily in recent years. It will grow from $2.04 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 2.7%. The growth in the historic period can
Leading Growth Driver in the Testosterone Replacement Therapy Market in 2025: Ri …
What market dynamics are playing a key role in accelerating the growth of the testosterone replacement therapy market? The testosterone replacement therapy market is anticipated to expand due to the increasing instances of testosterone deficiency, also known as hypogonadism-a condition characterized by insufficient testosterone production. Testosterone replacement therapy aims to effectively augment testosterone levels within normal physiological range, mitigating hypogonadism's effects and addressing issues like lowered libid*o, erectile dysfunction, depressive tendencies,
Testosterone Replacement Therapy Market: "Testosterone Replacement Therapy Marke …
Testosterone Replacement Therapy Market Scope: Key Insights : Testosterone Replacement Therapy Market size was valued at around USD 1.4 billion in 2022 and is expected to rise from USD 1.5 billion in 2023 to reach a value of USD 2.9 billion by 2031, at a CAGR of 8.9% over the forecast period (2024-2031). Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/testosterone-replacement-therapy-market In-Depth Exploration of the global Testosterone Replacement Therapy
Testosterone Booster Market Report 2024 - Testosterone Booster Market Trends And …
"The Business Research Company recently released a comprehensive report on the Global Testosterone Booster Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The testosterone booster market
MaleMax 100 Testosterone Booster
Male Max a hundred Male Enhancement is a male improve increment intended to recover and consummate your sexual electricity. Delicate curio support may additionally abstain you get your conviction again in the room. However, you impoverishment to reap reliable you consume the best enlargement in fee to get an outstanding elevate. What is Male Max 100 Enhancement? Male Max one hundred is a male improve be part of explicitly bear in mind
Rising Incidence of Testosterone Deficiency Continues to Propel Testosterone Rep …
Global Testosterone Replacement Therapy Market: Overview A range of testosterone replacement therapy (TRT) products formulated from various active ingredients are available in the market these days. At present around 30% of men worldwide suffer from hypogonadism or testosterone deficiency as shown by different studies. The percentage is substantial and in the near future it is slated to spike thereby likely effecting a demand jump for TRT products. The global market for